MedPath

EXTRA STRENGTH

KAOPECTATE Extra Strength Gas Relief Liquid

Approved
Approval ID

d45ec9d0-f8b9-41ef-8dd9-11caf6a1b3eb

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Apr 17, 2025

Manufacturers
FDA

KRAMER LABORATORIES

DUNS: 122720675

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SIMETHICONE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55505-225
Application NumberM002
Product Classification
M
Marketing Category
C200263
G
Generic Name
SIMETHICONE
Product Specifications
Route of AdministrationORAL
Effective DateApril 17, 2025
FDA Product Classification

INGREDIENTS (13)

CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIEDInactive
Code: K679OBS311
Classification: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POLYSORBATE 60Inactive
Code: CAL22UVI4M
Classification: IACT
POTASSIUM SORBATEInactive
Code: 1VPU26JZZ4
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
SORBITAN MONOSTEARATEInactive
Code: NVZ4I0H58X
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
SUCRALOSEInactive
Code: 96K6UQ3ZD4
Classification: IACT
XANTHAN GUMInactive
Code: TTV12P4NEE
Classification: IACT
DIMETHICONE, UNSPECIFIEDActive
Quantity: 125 mg in 5 mL
Code: 92RU3N3Y1O
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 11/20/2023

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 11/20/2023

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 11/20/2023

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 11/20/2023

WARNINGS SECTION

LOINC: 34071-1Updated: 11/20/2023

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 11/20/2023

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 11/20/2023

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 11/20/2023

OTC - QUESTIONS SECTION

LOINC: 53413-1Updated: 11/20/2023

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

EXTRA STRENGTH - FDA Drug Approval Details